A composite clinical stage for AIDS-related Kaposis sarcoma A refinement of the AIDS clinical trials group clinical staging classification
Shilling, R.A.; Subramanian, N.; Dowlati, A.; Gordon, S.; Ramnes, C.; Sedransk, N.; Lederman, M.; Remick, S.C.
JAIDS Journal of Acquired Immune Deficiency Syndromes 21(1): A23
1999
Document Number: 267164
Document emailed within 1 workday
Related Documents
Benson, C.A.; Williams, P.L.; Cohn, D.L.; Becker, S.; Hojczyk, P.; Nevin, T.; Korvick, J.A.; Heifets, L.; Child, C.C.; Lederman, M.M.; Reichman, R.C.; Powderly, W.G.; Notario, G.F.; Wynne, B.A.; Hafner, R. 2000: Clarithromycin or rifabutin alone or in combination for primary prophylaxis of Mycobacterium avium complex disease in patients with AIDS: A randomized, double-blind, placebo-controlled trial. The AIDS Clinical Trials Group 196/Terry Beirn Community Programs for Clinical Research on AIDS 009 Protocol Team Journal of Infectious Diseases 181(4): 1289-1297Gordin, F.; Chaisson, R.E.; Matts, J.P.; Miller, C.; de Lourdes Garcia, M.; Hafner, R.; Valdespino, J.L.; Coberly, J.; Schechter, M.; Klukowicz, A.J.; Barry, M.A.; O'Brien, R.J. 2000: Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS, the Adult AIDS Clinical Trials Group, the Pan American Health Organization, and the Centers for Disease Control and Prevention Study Group JAMA 283(11): 1445-1450
Feigal, E.G.; Phillips, P.H.; Cheson, B.D. 1997: Clinical Trials Referral Resource. Clinical trials in AIDS related malignancies Oncology 11(3): 337-338; 341
Hochster, H.; Dieterich, D.; Bozzette, S.; Reichman, R.C.; Connor, J.D.; Liebes, L.; Sonke, R.L.; Spector, S.A.; Valentine, F.; Pettinelli, C. 1990: Toxicity of combined ganciclovir and zidovudine for cytomegalovirus disease associated with AIDS. An AIDS Clinical Trials Group Study Annals of Internal Medicine 113(2): 111-117
Richman, D.; Itri, L.; Johnson, M.F.; Eigo, J. 1990: Methodological issues in AIDS clinical trials. Discussion. Design of clinical trials--active control (equivalence) trials Journal of Acquired Immune Deficiency Syndromes 3 Suppl. 2: S88
Edathodu, J.; Ali, B.; Alrajhi, A.A. 2009: CD4 validation for the World Health Organization classification and clinical staging of HIV/AIDS in a developing country International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 13(2): 243-246
Lietman, P.; Temple, R.; Harrington, M.; Peck, C. 1990: Methodological issues in AIDS clinical trials. Discussion. Design of clinical trials--approaches to clinical trials design Journal of Acquired Immune Deficiency Syndromes 3 Suppl. 2: S27
Sweeney, R.; Rose, V.L. 2000: NIAID renews funding for the adult AIDS clinical trials group American Family Physician 61(4): 940
Cheson, B.D.; Feigal, E.G. 1993: Clinical trials referral resource. AIDS-related non-Hodgkin's lymphomas Oncology 7(4): 37-38
Rasokat, H.; Häussermann, L.; Bauermeister-Jasso, K. 1985: Sporadic, endemic and AIDS-related Kaposi's sarcoma. Different clinical course variants of the tumor demonstrated by 3 typical cases Zeitschrift für Hautkrankheiten 60(1-2): 109-115
Shimoyama, M.; Tajima, K. 1993: Japan Clinical Oncology Group for cooperative cancer clinical trials and role of the statistical center in the management of cancer clinical trials Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(16): 2507-2518
Trimble, E.L.; Rowland, J.; Varricchio, C.; Gore-Langton, R.E. 2001: Clinical trials referral resource. Health-related quality of life in cancer clinical trials Oncology 15(5): 601
Rutstein, R.M.; Samson, P.; Fenton, T.; Fletcher, C.V.; Kiser, J.J.; Mofenson, L.M.; Smith, E.; Graham, B.; Mathew, M.; Aldrovani, G.; Rutstein, R.M.; Douglas, S.; Aldrovandi, G.; Kiser, J.; Fletcher, C.V.; Fenton, T.; Samson, P.; Graham, B.; Sprenger, H.L.; Mofenson, L.M.; Smith, E.; Purdue, L.; Kneut, C.; Ortiz, B.; Douglas, Q.; Petzold, E.; Myers, T.; Violari, A.; Gray, G.; Horga, M.; Schnittman, S.; Matthew, M.; Dieudonne, A.; Johnson, J.; Monti, L.; Bryson, Y.; Deville, J.G.; Nielsen-Saines, K.; Paul, M.; Hammill, H.; McMullen-Jackson, C.; Yogev, R.; Cagwin, E.; Williams, R.; Spector, S.A.; Viani, R.M.; Stangl, L.; Swetnam, J.; Wilson, J.; Donnelly, M.; Abrams, E.; Frere, M.; Calo, D.; Pelton, S.I.; McLaud, D.; Tucker, L.; Borkowsky, W 2015: Long-term safety and efficacy of atazanavir-based therapy in HIV-infected infants, children and adolescents: the Pediatric AIDS Clinical Trials Group Protocol 1020A Pediatric Infectious Disease Journal 34(2): 162-167
Dolin, R.; Amato, D.A.; Fischl, M.A.; Pettinelli, C.; Beltangady, M.; Liou, S.H.; Brown, M.J.; Cross, A.P.; Hirsch, M.S.; Hardy, W.D. 1995: Zidovudine compared with didanosine in patients with advanced HIV type 1 infection and little or no previous experience with zidovudine. AIDS Clinical Trials Group Archives of Internal Medicine 155(9): 961-974
Hermans, P.; Lundgren, J.; Sommereijns, B.; Pedersen, C.; Vella, S.; Katlama, C.; Lüthy, R.; Pinching, A.J.; Gerstoft, J.; Pehrson, P.; Clumeck, N. 1996: Epidemiology of AIDS-related Kaposi's sarcoma in Europe over 10 years. AIDS in Europe Study Group Aids 10(8): 911-917
1998: Assessment of EPS and tardive dyskinesia in clinical trials. Collaborative Working Group on Clinical Trial Evaluations Journal of Clinical Psychiatry 59 Suppl. 12: 23-27
Brentlinger, P.E.; Torres, J.V.; Martinez Martinez, P.; Ghee, A.; Lujan, J.; Bastos, R.; Manuel, R.; Mudender, F.M.; Assan, A. 2010: Clinical Staging of HIV-Related Illness in Mozambique: Performance of Nonphysician Clinicians Based on Direct Observation of Clinical Care and Implications for Health Worker Training Journal of Acquired Immune Deficiency Syndromes (1999) 55(3): 351-355
Oliveira, M.A.; Santos, E.M.; Mello, J.M. 2001: AIDS, activism, and the regulation of clinical trials in Brazil: Protocol 028 Cadernos de Saude Publica 17(4): 863-875
Nowak, R. 1995: AIDS researchers, activists fight crisis in clinical trials Science 269(5231): 1666-1667
Mallery, S.R.; Bailer, R.T.; Hohl, C.M.; Ng-Bautista, C.L.; Ness, G.M.; Livingston, B.E.; Hout, B.L.; Stephens, R.E.; Brierley, G.P. 1995: Cultured AIDS-related Kaposi's sarcoma (AIDS-KS) cells demonstrate impaired bioenergetic adaptation to oxidant challenge: implication for oxidant stress in AIDS-KS pathogenesis Journal of Cellular Biochemistry 59(3): 317-328